Skip to main content
. Author manuscript; available in PMC: 2013 May 17.
Published in final edited form as: Brain Stimul. 2011 Jun 14;5(3):320–9.e27. doi: 10.1016/j.brs.2011.05.003

Table 9. rTMS adverse events by positive sensory symptom.

Number of patients experiencing specified adverse events per positive sensory symptom. Total number patients with adverse event are given along with corresponding percentage of total patient population within positive sensory symptom.

AH (n =393) Tinnitus (n =877) Neuropathic Pain (n = 311) Migraine (n = 165) Fibromyalgia (n = 53)
Abdominal Pain 1 (0.25%) 0 0 0 0
Clicking Noise Persistence 1 (0.25%) 0 0 0 0
Concentration Difficulty 3 (0.76%) 0 0 0 0
Dizziness 3 (0.76%) 0 2 (0.64%) 1 (0.61%) 1 (1.89%)
Earache 1 (0.25%) 0 0 0 0
Fatigue/Drowsiness 1 (0.25%) 0 1 (0.32%) 4 (2.42%) 0
Headache 39 (9.92%) 44 (5.02%) 9 (2.89%) 3 (1.82) 16 (30.19%)
Hearing Problems 2 (0.51%) 0 0 1 (0.61%) 0
Hot/Cold Sensitivity 0 0 2 (0.64%) 0 0
Imbalance 0 1 (0.11%) 0 0 0
Irritability 0 0 0 1 (0.61%) 0
Ischemic Chest Pain 1 (0.25%) 0 0 0 0
Jaw Soreness 0 25 (2.85%) 0 0 0
Light-Headedness 5 (1.27%) 1 (0.11%) 0 0 0
Memory Difficulty 4 (1.02%) 0 0 0 0
Muscle Twitching 14 (3.56%) 19 (2.17%) 0 1 (0.61%) 0
Nausea 1 (0.25%) 0 0 1 (0.61%) 1 (1.89%)
Neck Pain 0 24 (2.74%) 3 (0.96%) 0 6 (11.32%)
Optic Neuritis 0 0 0 1 (0.61%) 0
Pain in Shoulder 0 0 0 0 0
Photophobia 0 1 (0.11%) 0 0 0
Psychiatric Symptom Exacerbation 6 (1.53%) 0 0 0 1 (1.89%)
Restlessness 1 (0.25%) 1 (0.11%) 0 0 0
Seizure 0 1 (0.11%) 2 (0.64%) 0 0
Scalp Discomfort 1 (0.25%) 0 0 0 0
Sinusitis 0 0 0 2 (1.21%) 0
Symptom Exacerbation 4 (1.02%) 19 (2.17%) 0 4 (2.42%) 0
Tingling Sensation 1 (0.25%) 1 (0.11%) 5 (1.61%) 0 0
Temple Pain 0 1 (0.11%) 0 0 0
Unpleasantness 0 5 (0.57%) 0 0 0
Vigorous Dreams 0 0 0 1 (0.61%) 0
Visual Hallucination 1 (0.25%) 0 0 0 0